All Investment Ideas
$73 mln$113 mln

IPO Health Catalyst

Leading IT platform for Healthcare
IPO
Medium risk

Revenues in 2017-2018

Invest in IPO Health Catalyst

This investment idea is no longer available. New applications are not accepted

View more ideas
Investment Idea Details
The Company

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations. Company’s Solution comprises a cloud-based data platform, analytics software, and professional services expertise.

Health Catalyst customers, which are primarily healthcare providers, use their Solution to manage data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.

For the years ended December 31, 2017 and 2018 total revenue was $73.1 million and $112.6 million, representing a 55% increase YoY.

The company achieved Dollar-based Retention Rates of 108% and 107% for the years ended December 31, 2017 and 2018, respectively.

Market Opportunity

The company estimates the addressable market for their data platform to be approximately $2 billion, analytics applications portfolio to be approximately $3 billion, and professional services offerings to be approximately $3 billion, which total an approximately $8 billion addressable market.

According to a 2019 market research report by MarketsandMarkets, the global healthcare analytics market was valued at $14 billion in 2019 and is projected to reach $50.5 billion by 2024, growing at a CAGR of 28.3% between 2019 and 2024.

Health Catalyst intends to grow their addressable market through new product offerings, international expansion, market adjacencies such as life sciences, and growth of relationships with risk-bearing entities.

Risks

The company is unprofitable and may not be able to achieve or sustain profitability in the future, which could lead to decline in share price.

The company faces intense competition and could lose market share to competitors, which could adversely affect business, financial condition, and results of operations.

Government regulation of healthcare creates risks and challenges with respect to compliance efforts and business strategies.

Financials

Recent IPOs in Biotech sector:
Guardant Health +105% 3-month return.
Twist Biosciences +65% 3-month return.

During the IPO, Health Catalyst will raise $138 million with a market cap of about $800 million (at $23 per share).

The company's LTM revenue was $127 million, while the quarterly revenue growth was 71%. The company shows steady growth in revenue, demonstrates a healthy balance sheet, increases customer base, provides a high net dollar based expansion rate and operates in a fast-growing promising market. According to our forecast, the company's market cap after an IPO could reach $1.4 billion, with an expected return on investment of 75%.

How IPO Investments Work
1. Collection of funds

2-3 weeks before the start of the company publishes information about the opening of trading: financial statements for 3 years, a description of the company's business, plans for the future, as well as the risks that management sees in their own business. We analyze such offers and publish the best ones. Investors apply for deposits. Before the deadline for applications, you can change the request or cancel it.

Publication
15 Jul
Threshold amount
$50
2. Buy shares

We submit one large application for the purchase of shares by pre-subscription with reduced price to large investors. The application may be rejected in part or in full. Over the past three years, our applications have been rejected only three times. The next day, or every other day, we'll know at what price and at what percentage the order is executed, and we'll post it on «The my investment page».

Submit applications before
21 Jul
3. Start Bidding

The price of shares is rising from the first day due to the demand of investors deprived of the opportunity to buy shares before trading. Most of the stocks we've been recommending buying over the past three years have been starting to trade on the stock exchange at tens of percent higher than the price at which customers bought the shares. There comes a Lock up period when it is forbidden to sell shares purchased by subscription. Typically lasts 3 months.

Start Bidding
25 Jul
Return forecast
+75%
4. Receiving profit

After the expiration of the Lock Up period, the investment is automatically closed and the investor receives a profit on account of the deduction commissions UT. You can always view the results of your past investments in investment archive.

End
26 Oct
Early profit fixation

Although no shares are allowed to be sold during the lock-up period, our traders seek to offer investors fixed profit by way of using various financial instruments, including forwards, options, short positions etc.

From the investor’s point of view this means that he or she may close an investment by paying a certain part of its value (as a rule, approximately 15 percent). This is due to high prices for the instruments which are employed to ensure availability of fixed profit. As such, you shall press any relevant button in the Investor Account as soon as it is active.

The closing procedure is similar to commencement of investment business. You shall file a bid which is executed within a business day by UT. So, your investment is closed at the price currently prevailing on the stock exchange. However, we rarely recommend using this feature, since upon expiry of an applicable lock-up period the average performance is higher.

Fee

FOR ENTRY

3 per cent of the share price. This fee is charged as soon as your investment bid is confirmed.

FOR EXIT

1.75 per cent of the purchase price paid for your shares as soon as trading is closed. This fee is charged upon closure of any relevant investment.

SUCCESS

20 per cent of the profit your derive. This fee is charged only if you show positive performance as of the moment any relevant investment is closed.

TO EARLY EXIT

Usually, 15 per cent (depends on the stock exchange environment). It is calculated per each investment individually.

Advantages Enjoyed by Those Investing with United Traders

RELIABILITY

Our risk managers ensure proper support throughout the entire transaction. Moreover, you may call them on +7 495 646-15-57 or 8 800 333-66-81 or visit our office, if a more detailed discussion is needed.

IN THE PROFIT FROM THE FIRST DAY

Such an approach allows it to limit extra risks related to bankruptcy of start-ups and considerably increase profit vs investors purchasing shares on open Market.

LOW ENTRY THRESHOLD

Millions of dollars are required to buy shares on a subscription basis. We have generated a pool of traders and investors which enables any newbie to participate in any transaction as aforesaid by investing just USD50 or more.

Invest in IPO Health Catalyst

This investment idea is no longer available. New applications are not accepted

View more ideas